U.S. flag

An official website of the United States government

NM_001122681.2(SH3BP2):c.1253C>T (p.Pro418Leu) AND Fibrous dysplasia of jaw

Germline classification:
Pathogenic/Likely pathogenic (4 submissions)
Last evaluated:
Jan 28, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000007983.10

Allele description

NM_001122681.2(SH3BP2):c.1253C>T (p.Pro418Leu)

Gene:
SH3BP2:SH3 domain binding protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4p16.3
Genomic location:
Preferred name:
NM_001122681.2(SH3BP2):c.1253C>T (p.Pro418Leu)
HGVS:
  • NC_000004.12:g.2831582C>T
  • NG_011609.1:g.43560C>T
  • NM_001122681.2:c.1253C>TMANE SELECT
  • NM_001145855.2:c.1337C>T
  • NM_001145856.2:c.1424C>T
  • NM_003023.4:c.1253C>T
  • NP_001116153.1:p.Pro418Leu
  • NP_001139327.1:p.Pro446Leu
  • NP_001139328.1:p.Pro475Leu
  • NP_003014.3:p.Pro418Leu
  • LRG_1334t1:c.1253C>T
  • LRG_1334t2:c.1337C>T
  • LRG_1334:g.43560C>T
  • LRG_1334p1:p.Pro418Leu
  • LRG_1334p2:p.Pro446Leu
  • NC_000004.11:g.2833309C>T
  • NM_001122681.1:c.1253C>T
  • NM_001122681.2:c.1253C>T
  • P78314:p.Pro418Leu
Protein change:
P418L; PRO418LEU
Links:
UniProtKB: P78314#VAR_013260; OMIM: 602104.0001; dbSNP: rs121909146
NCBI 1000 Genomes Browser:
rs121909146
Molecular consequence:
  • NM_001122681.2:c.1253C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001145855.2:c.1337C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001145856.2:c.1424C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003023.4:c.1253C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Fibrous dysplasia of jaw (CRBM)
Synonyms:
Cherubism
Identifiers:
MONDO: MONDO:0007315; MedGen: C0008029; Orphanet: 184; OMIM: 118400

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000028188OMIM
no assertion criteria provided
Pathogenic
(Jun 1, 2001)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000996316Clinical Genetics Laboratory, Federal University of Health Sciences of Porto Alegre
no assertion criteria provided
Pathogenic
(Mar 18, 2019)
maternalresearch

SCV001223199Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Apr 16, 2021)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

SCV002577549Laboratory of Medical Genetics, National & Kapodistrian University of Athens
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 28, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedmaternalyes1not providednot provided1yesresearch
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A new mutation in the SH3BP2 gene showing reduced penetrance in a family affected with cherubism.

de Lange J, van Maarle MC, van den Akker HP, Redeker EJ.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103(3):378-81. Epub 2006 Sep 26. No abstract available.

PubMed [citation]
PMID:
17321449

Investigation of the SH3BP2 gene mutation in cherubism.

Lee JY, Jung YS, Kim SA, Lee SH, Ahn SG, Yoon JH.

Acta Med Okayama. 2008 Jun;62(3):209-12.

PubMed [citation]
PMID:
18596838
See all PubMed Citations (9)

Details of each submission

From OMIM, SCV000028188.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Ueki et al. (2001) found a pro418-to-leu (P418L) mutation of the SH3BP2 gene in patients with cherubism (118400).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Clinical Genetics Laboratory, Federal University of Health Sciences of Porto Alegre, SCV000996316.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providedyesresearchnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyes1not provideddiscovery1not providednot providednot provided

From Invitae, SCV001223199.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This variant disrupts the p.Pro418 amino acid residue in SH3BP2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17321449, 18596838, 28644570, 23298620, 11381256). This suggests that this residue is clinically-significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has been reported to affect SH3BP2 protein function (PMID: 22153077). This variant has been observed in individuals and families affected with cherubism (PMID: 11381256, 27272835, 23298620). ClinVar contains an entry for this variant (Variation ID: 7547). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with leucine at codon 418 of the SH3BP2 protein (p.Pro418Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Laboratory of Medical Genetics, National & Kapodistrian University of Athens, SCV002577549.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

PS4, PM1, PM5, PM2, PP3, PP5

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 14, 2024